Email Alert | RSS

北京大学学报（医学版） ›› 2022, Vol. 54 ›› Issue (2): 244-248. doi: 10.19723/j.issn.1671-167X.2022.02.007

• 论著 • 上一篇    下一篇

雌马酚及其对应异构体抑制乌拉坦诱导小鼠肺癌发生率

于雪,邹永秋,王颖,陈泽琨,马德福()   

  1. 北京大学公共卫生学院社会医学与健康教育系,北京 100191
  • 收稿日期:2020-01-09 出版日期:2022-04-18 发布日期:2022-04-13
  • 通讯作者: 马德福 E-mail:madefu@bjmu.edu.cn
  • 基金资助:
    国家自然科学基金(81573130);北京市自然科学基金(7172117);北京市自然科学基金(S160004)

Equol and its enantiomers inhibited urethane-induced lung cancer in mice

YU Xue,ZOU Yong-qiu,WANG Ying,CHEN Ze-kun,MA De-fu()   

  1. Department of Social Medicine and Health Education, Peking University School of Public Health, Beijing 100191, China
  • Received:2020-01-09 Online:2022-04-18 Published:2022-04-13
  • Contact: De-fu MA E-mail:madefu@bjmu.edu.cn
  • Supported by:
    National Natural Science Foundation of China(81573130);Beijing Natural Science Foundation(7172117);Beijing Natural Science Foundation(S160004)

RICH HTML

 12   

PDF (PC)

189

摘要：

目的: 探讨外消旋雌马酚及其对应异构体对乌拉坦诱导小鼠肺癌的影响及其可能机制。方法: 120只小鼠随机分为8组,实验组予以染料木素或不同剂量的雌马酚,每周2次连续4周皮下注射乌拉坦后测量并记录各组小鼠体质量、摄食量和肺癌发生率。处死小鼠后收集小鼠血液、肝和肺,用相应的试剂盒检测血清中超氧化物歧化酶(superoxide dismutase, SOD)、丙二醛(malondialdehyde, MDA)和8-羟基脱氧鸟嘌呤(8-hydroxydeoxygunosine, 8-OHdG)的含量,蛋白免疫印迹法检测肝中核因子红系2相关因子2[nuclear factor(erythroid-derived 2)-like 2, Nrf2]的表达。结果: 120只小鼠中49只出现肺癌,肺癌总体发生率为40.8%。与喂养基础饲料的对照组相比,各实验组肺癌发生率均更低,且差异具有统计学意义,同种药物高剂量实验组肺癌发生率显著低于低剂量实验组,但是同等剂量下3种雌马酚组和染料木素组小鼠肺癌发生率相当。与对照组相比,高剂量实验组小鼠血清中SOD含量更高,MDA和8-OHdG的含量更低,且差异具有统计学意义。蛋白免疫印迹检测结果显示,除低剂量外消旋雌马酚组外其余各组小鼠的Nrf2蛋白表达水平均高于对照组小鼠,并且同种药物高剂量雌马酚组的Nrf2蛋白表达水平高于低剂量雌马酚组。结论: 雌马酚及其对应异构体可能通过抗氧化效应抑制肺癌的发生。

关键词: 雌马酚, 雌马酚对应异构体, 肺癌, 抗氧化活性, 核因子红系2相关因子2(Nrf2)

Abstract:

Objective: To investigate the effects and mechanisms of equol and its enantiomers on urethane-induced lung cancer in mice. Methods: A total of 120 5-week-old male C57BL/6 mice were randomly divided into 8 groups: lung cancer tumor control group (CG), genistein control group (GCG), low dose racemic equol group (LEG), high dose racemic equol group (HEG), low dose R-equol group (LRE), high dose R-equol group (HRE), low dose S-equol group (LSE) and high dose S-equol group (HSE). Urethane was injected subcutaneously twice a week for 4 weeks to induce lung cancer and then the mice were fed for 4 months. The body weight and food intake of each group were measured and recorded weekly. After the mice were sacrificed, the blood, livers and lungs of the mice were collected. The incidence of lung cancer in each group was recorded. The concentration of serum superoxide dismutase (SOD), malondialdehyde (MDA) and 8-hydroxydeoxygunosine (8-OHdG) were detected by the corresponding kits. Western blotting was used to detect the expression of nuclear factor (erythroid-derived 2)-like 2 (Nrf2) in the livers. Between-group differences in body weight and food intake of the mice were compared using repeated measures ANOVA, and ANOVA for the differences between non-repeated measurements, with post hoc analysis using Tukey’s method if there were between-group differences. Comparisons of categorical data were performed by chi-square test, and if there were differences between the groups, the Bonferroni method was used for pairwise comparison. Results: A total of 49 in the 120 mice developed lung cancer. The overall incidence of lung cancer was 40.8%. Compared with the control group, the incidence of lung cancers in each experimental group was lower, and the difference was statistically significant. The incidence of lung cancer in the high-dose experimental group was significantly lower than that in the low-dose experimental group. However, the incidence of lung cancer was similar in the three equol groups and the genistein group at the same dose. Compared with the control group, the high-dose experimental group had higher serum SOD concentration, lower MDA and 8-OHdG concentrations, and the differences were statistically significant. Western blotting analysis showed that the expression levels of Nrf2 protein in the experimental groups were higher than those in the control group except the low-dose racemic equol group, and the Nrf2 protein expression level in the high-dose equol groups was higher than that in the low-dose equol groups. Conclusion: Racemic equol and its enantiomers mayinhibit lung carcinogenesis through antioxidant effects.

Key words: Equol, Equol enantiomers, Lung cancer, Antioxidant activity, Nuclear factor (erythroid-derived 2)-like 2 (Nrf2)

中图分类号: 

  • R73-35+4

表1

各实验组饲料成分"

Group Diets
CG modified AIN-93G diet
GCG modified AIN-93G diet+500 mg/kg genistein
LEG modified AIN-93G diet+250 mg/kg equol
HEG modified AIN-93G diet+500 mg/kg equol
LRE modified AIN-93G diet+250 mg/kg R-equol
HRE modified AIN-93G diet+500 mg/kg R-equol
LSE modified AIN-93G diet+250 mg/kg S-equol
HSE modified AIN-93G diet+500 mg/kg S-equol

图1

实验期间小鼠体质量周变化情况"

图2

实验期间小鼠单位体质量食物摄入量周变化情况"

表2

各组小鼠肺癌发生情况"

Group Total Number of cases of
lung cancer		 Incidence of
lung cancer/%
CG 15 13 86.7
GCG 15 3 20.0#
LEG 15 9 60.0*
HEG 15 3 20.0#
LRE 15 8 53.3*
HRE 15 2 13.3#
LSE 15 9 60.0*
HSE 15 2 13.3#

表3

各组小鼠血清中氧化/抗氧化指标结果"

Group SOD MDA 8-OHdG
CG 59.70±12.72 3.48±0.12 7.16±0.38
GCG 68.50±2.09# 2.85±0.54# 6.08±0.65#
LEG 54.55±14.65 3.24±0.18 6.51±0.22#
HEG 64.02±6.47 2.61±0.43# 5.41±0.55#
LRE 64.86±10.49 3.04±0.86# 6.45±0.40#
HRE 70.61±1.88# 2.27±0.25# 5.39±0.64#
LSE 61.40±11.60 3.04±0.60# 6.88±0.70
HSE 70.27±5.19# 2.51±0.42# 5.62±0.71#

图3

各组小鼠Nrf2蛋白的表达情况"

[1] Herbst RS, Heymach JV, Lippman SM. Lung cancer[J]. N Engl J Med, 2008, 359(13):1367-1380.
doi: 10.1056/NEJMra0802714
[2] Siegel RL, Miller KD, Jemal A. Cancer statistics, 2020[J]. CA Cancer J Clin, 2020, 70(1):7-30.
doi: 10.3322/caac.v70.1
[3] 陈万青, 张思维, 邹小农. 中国肺癌发病死亡的估计和流行趋势研究[J]. 中国肺癌杂志, 2010, 13(5):488-493.
[4] Chen W, Zheng R, Baade PD, et al. Cancer statistics in China, 2015[J]. CA Cancer J Clin, 2016, 66(2):115-132.
doi: 10.3322/caac.21338
[5] Kumarakulasinghe NB, van Zanwijk N, Soo RA. Molecular targeted therapy in the treatment of advanced stage non-small cell lung cancer (NSCLC)[J]. Respirology, 2015, 20(3):370-378.
doi: 10.1111/resp.12490 pmid: 25689095
[6] Miller KD, Nogueira L, Mariotto AB, et al. Cancer treatment and survivorship statistics, 2019[J]. CA Cancer J Clin, 2019, 69(5):363-385.
doi: 10.3322/caac.v69.5
[7] Shi J, Zhu J. Health resource utilization in patients with advanced non-small cell lung cancer receiving chemotherapy in China[J]. Clin Drug Investig, 2016, 36(1):77-86.
doi: 10.1007/s40261-015-0356-9
[8] Zhong L, Yang J, Cao Z, et al. Preclinical pharmacodynamic evaluation of drug candidate SKLB-178 in the treatment of non-small cell lung cancer[J]. Oncotarget, 2017, 8(8):12843-13854.
doi: 10.18632/oncotarget.14597 pmid: 28086226
[9] Norat T, Aune D, Chan D, et al. Fruits and vegetables: Updating the epidemiologic evidence for the WCRF/AICR lifestyle recommendations for cancer prevention[J]. Cancer Treat Res, 2014, 159:35-50.
[10] Muthyala RS, Ju YH, Sheng S, et al. Equol, a natural estrogenic metabolite from soy isoflavones: Convenient preparation and resolution of R- and S-equols and their differing binding and biological activity through estrogen receptors alpha and beta[J]. Bioorg Med Chem, 2004, 12(6):1559-1567.
[11] Brown NM, Belles CA, Lindley SL, et al. The chemopreventive action of equol enantiomers in a chemically induced animal model of breast cancer[J]. Carcinogenesis, 2010, 31(5):886-893.
doi: 10.1093/carcin/bgq025
[12] Zhou T, Meng C, He P. Soy Isoflavones and their effects on xenobiotic metabolism[J]. Curr Drug Metab, 2019, 20(1):46-53.
doi: 10.2174/1389200219666180427170213
[13] Ma D, Zhang Y, Yang T, et al. Isoflavone intake inhibits the development of 7,12-dimethylbenz(a)anthracene(DMBA)-induced mammary tumors in normal and ovariectomized rats[J]. J Clin Biochem Nutr, 2014, 54(1):31-38.
doi: 10.3164/jcbn.13-33
[14] Mayo B, Vázquez L, Flórez AB. Equol: A bacterial metabolite from the daidzein isoflavone and its presumed beneficial health effects[J]. Nutrients, 2019, 11(9):2231.
doi: 10.3390/nu11092231
[15] Lignitto L, LeBoeuf SE, Homer H, et al. Nrf2 activation promotes lung cancer metastasis by inhibiting the degradation of bach1[J]. Cell, 2019, 178(2): 316.e18-329. e18.
doi: S0092-8674(19)30631-2 pmid: 31257023
[16] Mohs A, Otto T, Schneider KM, et al. Hepatocyte-specific NRF2 activation controls fibrogenesis and carcinogenesis in steatohepatitis[J]. J Hepatol, 2021, 74(3):638-648.
doi: 10.1016/j.jhep.2020.09.037
[1] 朱巧,任翠,张艳,李美娇,王晓华. 能谱CT诊断非小细胞肺癌纵隔淋巴结转移的应用价值[J]. 北京大学学报（医学版）, 2020, 52(4): 730-737.
[2] 欧阳雨晴,倪莲芳,刘新民. 恶性孤立性肺结节患者预后因素分析[J]. 北京大学学报（医学版）, 2020, 52(1): 158-162.
[3] 张春凤,刘云,陆敏,杜晓娟. hUTP14a在非小细胞肺癌组织中的表达[J]. 北京大学学报（医学版）, 2019, 51(1): 145-150.
[4] 马闰卓，邱敏，何为，杨斌，夏海缀，邹达，陆敏，马潞林，卢剑. 输尿管镜活检可协助上尿路尿路上皮癌危险分层[J]. 北京大学学报(医学版), 2017, 49(4): 632-637.
[5] 蔡源发，张华明，钮文异，邹永秋，马德福. 雌马酚对大肠癌细胞增殖的影响[J]. 北京大学学报(医学版), 2017, 49(3): 383-387.
[6] 赵晓慧, 胡建伟, 张玉梅, 王培玉. 雌马酚对二甲基苯蒽诱导的去势大鼠乳腺肿瘤的影响[J]. 北京大学学报（医学版）, 2011, 43(3): 348-351.
Viewed
Full text


Abstract

Cited
  Shared   
  Discussed   
[1] 成刚, 钱振华, 胡军. 艾滋病项目自愿咨询检测的技术效率分析[J]. 北京大学学报（医学版）, 2009, 41(2): 135 -140 .
[2] 李宏亮*, 安卫红*, 赵扬玉, 朱曦. 妊娠合并高脂血症性胰腺炎行血液净化治疗1例[J]. 北京大学学报（医学版）, 2009, 41(5): 599 -601 .
[3] 刘津, 王玉凤. 父母培训对共患对立违抗性障碍的注意缺陷多动障碍的作用[J]. 北京大学学报（医学版）, 2007, 39(3): 310 -314 .
[4] 汪毅, 刘粹, 王玉凤. 社会技能训练对有行为问题儿童影响的随机对照研究[J]. 北京大学学报（医学版）, 2007, 39(3): 315 -318 .
[5] 于涛, 王振宇, 马长城. 椎管内非特异性外周T细胞淋巴瘤一例[J]. 北京大学学报（医学版）, 2007, 39(4): 343 -345 .
[6] 牟向东, 王广发, 刁小莉, 阙呈立. 肺黏膜相关淋巴组织型边缘区B细胞淋巴瘤一例[J]. 北京大学学报（医学版）, 2007, 39(4): 346 -350 .
[7] 韩金涛, 赵军, 栾景源, 张龙. 多发结核性腹主动脉瘤一例[J]. 北京大学学报（医学版）, 2007, 39(4): 361 -364 .
[8] 燕太强, 杨荣利, 郭卫, 沈丹华. 胫骨平滑肌肉瘤伴全身多发骨转移一例[J]. 北京大学学报（医学版）, 2007, 39(4): 369 -373 .
[9] 吴红花, 高燕明, 郭晓蕙. 以上消化道出血为主诉的原发性甲状旁腺功能亢进症一例[J]. 北京大学学报（医学版）, 2007, 39(4): 374 -376 .
[10] 李西慧, 肖锋, 李岩, 杜迎利, 宋乃庆, 张明礼. 川崎病合并心肌梗死临床治疗一例[J]. 北京大学学报（医学版）, 2007, 39(4): 381 -384 .
ISSN 1671-167X
CN 11-4691/R
主管单位：中华人民共和国教育部
主办单位：北京大学
地址： 北京市海淀区学院路38号 北京大学医学部 《北京大学学报（医学版）》
邮编：100191
电话：010-82801551
Email： xbbjb2@bjmu.edu.cn

《北京大学学报（医学版）》
微信公众号
版权所有 © 2018 《北京大学学报（医学版）》编辑部